N-Phenylacetyl-l-prolylglycine ethyl ester is promoted as a nootropic and is a prodrug of cycloprolylglycine. Other names include the brand name Noopept, developmental code GVS-111; proposed INN omberacetam. Its synthesis was first reported in 1996.
Noopept is widely touted as a “nootropic”, or “cognitive enhancer” drug which may have some key advantages over other common nootropic. It is a powerful, fast-acting nootropic that’s an efficient brain booster and a potent neuroprotectant. It’s similar in structure to Piracetam but up to 1,000 times more effective.